XellSmart's Allogeneic iPSC-derived Cell Therapies for Parkinson's Disease and ALS Officially Approved by the U.S. FDA for Phase I Clinical Trials SUZHOU, China, April 15, 2025 /PRNewswire/ — In January 2025 (U.S. time),… April 15, 2025
CIRQUE DU SOLEIL INTRODUCES NEW INTERACTIVE DIGITAL EXPERIENCE, OFFERING BACKSTAGE ACCESS TO FANS Experience the world of KURIOS – Cabinet of Curiosities like never before… April 15, 2025
Reolink Earth Day 2025: Partnering with NGOs to Drive Global Conservation LOS ANGELES, April 15, 2025 /PRNewswire/ — It starts with a moment… April 15, 2025
SECuRE trial update: First patient treated in the Phase II Cohort Expansion HIGHLIGHTS The first of the planned 24 participants in the Cohort Expansion… April 15, 2025
Complete Genomics Names Four Winners of Spatial Xcellerator Grant Program SAN JOSE, Calif., April 15, 2025 /PRNewswire/ — Complete Genomics, a leading innovator… April 15, 2025
Cellid raises over $7.5 Million to strengthen development of displays for AR glasses TOKYO, April 15, 2025 /PRNewswire/ — Cellid Inc., a leading developer of… April 15, 2025
PGYTECH Showcases Innovation Success at NAB 2025 with New Releases LAS VEGAS, April 15, 2025 /PRNewswire/ — The 2025 National Association of… April 15, 2025
GIGABYTE Debuts GeForce RTX™ 5060 Ti & 5060 with Advanced Cooling System for Ultimate Gaming and AI TAIPEI, April 15, 2025 /PRNewswire/ — GIGABYTE, the world’s leading computer brand,… April 15, 2025
